Primary cardiac angiosarcoma is extremely aggressive; however, it is often misdiagnosed because of its rarity. For locally advanced tumors, doxorubicin-based chemotherapy regimens are the standard of treatment, even if the gain in term of progression-free survival is limited and is no longer than 5 months.
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma / Minichillo, Santino; Pantaleo, Maria Abbondanza; Nannini, Margherita; Coccolo, Fabio; Gatto, Lidia; Biasco, Guido; Brandi, Giovanni. - In: BMC RESEARCH NOTES. - ISSN 1756-0500. - STAMPA. - 8:1(2015), pp. 325.1-325.4. [10.1186/s13104-015-1296-4]
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma
MINICHILLO, SANTINO;PANTALEO, MARIA ABBONDANZA;NANNINI, MARGHERITA;GATTO, LIDIA;BIASCO, GUIDO;BRANDI, GIOVANNI
2015
Abstract
Primary cardiac angiosarcoma is extremely aggressive; however, it is often misdiagnosed because of its rarity. For locally advanced tumors, doxorubicin-based chemotherapy regimens are the standard of treatment, even if the gain in term of progression-free survival is limited and is no longer than 5 months.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s13104-015-1296-4.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
935.45 kB
Formato
Adobe PDF
|
935.45 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
